A detailed history of State Of Wisconsin Investment Board transactions in Incyte Corp stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 148,680 shares of INCY stock, worth $10.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
148,680
Previous 157,685 5.71%
Holding current value
$10.2 Million
Previous $9.56 Million 2.81%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$57.33 - $68.61 $516,256 - $617,833
-9,005 Reduced 5.71%
148,680 $9.83 Million
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $218,948 - $272,722
4,278 Added 2.79%
157,685 $9.56 Million
Q1 2024

May 14, 2024

SELL
$56.55 - $66.59 $297,679 - $350,529
-5,264 Reduced 3.32%
153,407 $8.74 Million
Q4 2023

Feb 12, 2024

BUY
$52.16 - $64.19 $2.46 Million - $3.03 Million
47,226 Added 42.38%
158,671 $9.96 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $736,683 - $840,739
12,752 Added 12.92%
111,445 $6.44 Million
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $1.41 Million - $1.75 Million
-23,157 Reduced 19.0%
98,693 $6.14 Million
Q1 2023

May 15, 2023

SELL
$70.23 - $86.01 $2.27 Million - $2.78 Million
-32,289 Reduced 20.95%
121,850 $8.81 Million
Q4 2022

Feb 14, 2023

SELL
$67.18 - $84.11 $1.5 Million - $1.88 Million
-22,386 Reduced 12.68%
154,139 $12.4 Million
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $1.83 Million - $2.29 Million
-27,692 Reduced 13.56%
176,525 $11.8 Million
Q2 2022

Aug 15, 2022

BUY
$66.18 - $83.18 $587,810 - $738,804
8,882 Added 4.55%
204,217 $15.5 Million
Q1 2022

May 13, 2022

BUY
$66.02 - $79.71 $3.47 Million - $4.19 Million
52,515 Added 36.77%
195,335 $15.5 Million
Q4 2021

Feb 11, 2022

BUY
$63.34 - $74.11 $2.5 Million - $2.93 Million
39,528 Added 38.27%
142,820 $10.5 Million
Q3 2021

Nov 12, 2021

SELL
$68.67 - $84.02 $3.36 Million - $4.11 Million
-48,901 Reduced 32.13%
103,292 $7.1 Million
Q2 2021

Aug 12, 2021

SELL
$79.87 - $87.53 $569,712 - $624,351
-7,133 Reduced 4.48%
152,193 $12.8 Million
Q1 2021

May 17, 2021

SELL
$76.02 - $100.5 $13.1 Million - $17.4 Million
-172,730 Reduced 52.02%
159,326 $12.9 Million
Q4 2020

Feb 03, 2021

SELL
$80.74 - $97.7 $1.5 Million - $1.82 Million
-18,630 Reduced 5.31%
332,056 $28.9 Million
Q3 2020

Nov 16, 2020

BUY
$85.07 - $109.69 $6.32 Million - $8.14 Million
74,250 Added 26.86%
350,686 $31.5 Million
Q2 2020

Aug 12, 2020

BUY
$74.18 - $108.93 $8.17 Million - $12 Million
110,126 Added 66.22%
276,436 $28.7 Million
Q1 2020

May 06, 2020

SELL
$63.18 - $85.97 $3.3 Million - $4.49 Million
-52,267 Reduced 23.91%
166,310 $12.2 Million
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $4.08 Million - $5.35 Million
-55,890 Reduced 20.36%
218,577 $19.1 Million
Q3 2019

Nov 12, 2019

SELL
$72.82 - $86.52 $13 Million - $15.5 Million
-178,822 Reduced 39.45%
274,467 $20.4 Million
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $4.37 Million - $5.27 Million
59,433 Added 15.09%
453,289 $38.5 Million
Q1 2019

May 13, 2019

BUY
$63.56 - $88.17 $2.72 Million - $3.77 Million
42,780 Added 12.19%
393,856 $33.9 Million
Q4 2018

Feb 11, 2019

BUY
$58.5 - $69.94 $8.01 Million - $9.58 Million
136,920 Added 63.93%
351,076 $22.3 Million
Q3 2018

Nov 14, 2018

BUY
$61.75 - $74.23 $3.53 Million - $4.24 Million
57,092 Added 36.35%
214,156 $14.8 Million
Q2 2018

Aug 03, 2018

SELL
$60.85 - $83.98 $5.11 Million - $7.06 Million
-84,049 Reduced 34.86%
157,064 $10.5 Million
Q1 2018

May 07, 2018

SELL
$83.06 - $100.98 $3.21 Million - $3.91 Million
-38,679 Reduced 13.82%
241,113 $20.1 Million
Q4 2017

Feb 08, 2018

BUY
$93.56 - $116.6 $2.53 Million - $3.15 Million
27,032 Added 10.69%
279,792 $26.5 Million
Q3 2017

Nov 01, 2017

BUY
$109.15 - $138.27 $27.6 Million - $34.9 Million
252,760
252,760 $29.5 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.